Abstract
The potential of gene therapy strategies for malignant gliomas that are based on retroviral-mediated transfer of a “suicide gene” such as Herpes Simplex Virus-thymidine kinase HSV-tk and subsequent treatment by a prodrug (ganciclovir, for example), has been emphasized by the promising results obtained by several groups. However, further experimental data as well as preliminary clinical results indicate that the low efficiency of retroviral-mediated gene transfer in vivo as well as difficulties for the diffusion of the prodrug inside the tumour mass can limit the efficacy of this form of gene therapy.
To achieve a more effective limitation of tumour growth other approaches may be combined with the “suicide gene” strategy and the enhancement of the immunological response to the tumour by cytokine gene transfer is prominent among these approaches. The authors’ experiments in nude mice confirm the antineoplastic role of IL-4 and encourage testing the effects of the simultaneous transfer of IL-4 and HSV-tk genes in immunocompetent animals.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barba D, Hardin J, Jasodhara R, Gage FH (1993) Thymidine kinase-mediated killing of rat brain tumors. J Neurosurg 79: 729–735
Barba D, Hardin J, Sadelain M, Gage FH (1994) Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 91:4348–4352
Benedetti S, DiMeco F, Colombo BM, Cirenei N, Pollo B, Bruzzone MG, Vescovi A, Colombo MP, DiDonato S, Finocchiaro G: Limits of the HSV-TK/GCV system for gene therapy of malignant gliomas: perspectives for the combined transduction of the IL-4 gene. Submitted
Beyer EC, Paul DL, Goodenough DA (1990) J Membr Biol 116: 187–194
Brooks WH, Markersbery WR, Gupta D, Roszman TL (1978) Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 2: 219–224
Colombo BM, Benedetti S, Ottolenghi S, Poli G, Pollo B, Mora M, Finocchiaro G (1995) The “bystander effect”: association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 6: 763–772
Cool V, Pirotte B, Gérard C, Dargent J-L, Baudson N, Levivier M, Goldman S, Hildebrand J, Brotchi J, Velu T (1996) Curative potential of Herpes Simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum Gene Ther 7: 627–635
Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550–1552
Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713–716
Izquierdo M, Cortes M, de Felipe P, Martin V, Diez-Guerra J, Talavera A, Perez-Higuera A (1995) Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Therapy 2: 66–69
Li Bi W, Parysek LM, Warnick R, Stambrook PJ (1993) Hum Gene Ther 4: 725–731
Mahaley MS jr, Brooks WH, Roszman TL (1977) Immunobiology of primary intracranial tumors. I. Studies of the cellular and humoral general immune competence of brain tumor patients. J Neurosurg 46: 467–476
Markowitz D, Goff S, Bank A (1988) Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167: 400–406
Pericle F, Giovarelli M, Colombo MP, Ferrari G, Musiani P, Modesti A, Cavallo F, DiPierro F, Novelli F, Forni G (1994) An efficient Th2-type memory follows CD8 + lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol 153: 5659–5673
Ram Z, Culver K, Oshiro E, Viola J, de Vroom H, Otto E, Long Z, McGarrity G, Muul G, Katz D, Blaese RM (1995) Summary of results and conclusion of the gene therapy of malignant brain tumors: clinical study. J Neurosurg 82: 343A
Sacco MG, Benedetti S, Duflot-Dancer A, Mesnil M, Bagnasco L, Strina D, Fasolo V, Villa A, Macchi P, Faranda S, Vezzoni P, Finocchiaro G (1996) Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retroviral mediated HSV-TK transfer in vivo. Gene Ther in press
Schold SC (1995) Placebo controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345: 1008–1012
Tepper RI, Pattengale PK, Leder P (1989) Murine Interleukin-4 displays potent anti-tumor activity in vivo. Cell 57: 503–512
Tepper RI, Coffman RL, Leder P (1992) An eosinophildependent mechanism for the antitumor effect of interleukin-4. Science 257: 548–551
Thomas DG, Lannigan CB, Behan PO (1975) Impaired cell mediated immunity in human brain tumors. Lancet 1: 1389–1390
Vile RG, Nelson JA, Castleden S, Chong H, Hart IR (1994) Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res 54: 6228–6234
Wei MX, Tamiya T, Hurford RK, Boviatsis EJ, Tepper RI, Chiocca EA (1995) Enhancement of interleukin 4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum Gene Ther 6: 437–443
Yu JS, Wei MX, Chiocca EA, Martuza L, Tepper RI (1993) Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res 53: 3125–3128
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1997 Springer-Verlag Wien
About this paper
Cite this paper
Benedetti, S. et al. (1997). Gene Transfer of Suicide Genes for the Treatment of Malignant Gliomas: Efficacy, Limitations, and Perspectives for a Combined Immunotherapy. In: Ostertag, C.B., Thomas, D.G.T., Bosch, A., Linderoth, B., Broggi, G. (eds) Advances in Stereotactic and Functional Neurosurgery 12. Acta Neurochirurgica Supplements, vol 68. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6513-3_19
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6513-3_19
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7341-1
Online ISBN: 978-3-7091-6513-3
eBook Packages: Springer Book Archive